• 收購內地婦兒科著名醫療集團「諾亞醫療」增 15 間中高端診所
• 與內地眼科醫療權威「惟視眼科」建立戰略合作夥伴關係，將在 18 個月内建兩間眼科中心

香港，2022 年 6 月 9 日 – 新世界集團旗下的優質醫療健康品牌 Humansa （仁山優社）今天宣布將擴展粵港澳大灣區業務，其版圖將於本年內擴充至擁有逾 30 個醫健佈點，由超過 350 名專業醫生提供更多元化的優質專科服務。現時內地團隊及主要合作夥伴已滿足逾 300,000 名顧客的醫療需求，Humansa 將會繼續拓展大灣區高端醫健服務市場，並與擁有 2,100 萬名潛在客戶的新世界生態圈產生協同效應，為集團帶來高增長的經常性收入。

透過收購內地婦兒科著名醫療集團諾亞醫療，以及與內地眼科醫療權威惟視眼科建立策略合作夥伴關係，Humansa 於大灣區的發展得以快速增長，延伸至香港市場外，以廣州及深圳為重點城市的內地市場，有助 Humansa 打入內地個人化及優質醫健服務市場。

Humansa 行政總裁蘇嘉威先生表示：「為配合粵港澳大灣區日益增加的高質素醫健需求，Humansa將持續擴展優質服務，部分更設有個人化體驗。在與新世界集團生態圈的協同效應及戰略合作夥伴的共同協作下，我們希望進一步擴展大灣區內的業務版圖，並為提供頂尖的綜合醫健

將諾亞醫療引進新世界集團生態系統

作為醫療服務百強企業，諾亞醫療將策略性地融入 Humansa 在大灣區的發展藍圖，滿足內地市民對中高端專科診所的服務需求。創辦於 2016年，諾亞醫療現成為領先業界、為顧客提供全面醫健服務的集團，包括兒科、婦產科、牙科、皮膚科、營養諮詢等，八成業務集中於大灣區。截止2022 年 4 月，諾亞醫療已擁有 15 間中高端診所，由超過 300 位來自內地「三甲」醫院的醫生提供醫療服務，同時在廣州及深圳具備強大的高端市場客戶網絡。

是次收購計劃為諾亞醫療成為 Humansa 在大灣區其中一個核心平台，透過共享客戶群、醫療資源、營運及管理優化等提升協同效應。諾亞醫療奠定了服務女性及兒童客戶的堅實基礎，通過是次收購，Humansa 將為客戶群及其家人提供高質素醫健服務。除了現有的服務，諾亞醫療亦會為客戶增設包括眼科護理等的醫健服務，進一步擴展其業務範疇。Humansa 希望藉此借助諾亞醫療於大灣區的網絡及專業醫護團隊，實現其成為大灣區優質醫療服務領袖的策略目標。

Mr Su Wei and Ms Huang Min, Co-founders of Noah Healthcare, said, “Following our rapid growth over the past six years, Noah Healthcare has accumulated successful experiences and rich resources in the field of high-end health services targeting women and children. It is an exciting growth opportunity for us to join the New World Group family under Humansa. As Humansa’s key platform in the mainland, we look forward to further contributing to the development and integration of medical and health services in the Greater Bay Area.”

聯手惟視眼科提升國內眼科護理市場的領導力

The partnership with Visionly will broaden Humansa’s breadth of specialities into eye care. On the back of Visionly’s leadership in ophthalmology, Humansa will provide eye examination and orthokeratology services in the Greater Bay Area. Over the next 18 months, Humansa and Visionly will build two ophthalmology centers in Guangzhou and Shenzhen.

Visionly is one of the fastest growing optometry brands in Mainland China. It currently operates the New Vision Hospital along with five optometry clinics, enabling it to holistically fulfil all optometry and ophthalmology diagnosis and treatment needs. Ms Yang Lin, Visionly’s Co-founder & Chief Executive Officer, has substantial worldwide pharmaceutical experience and a background in medicine. In 2014, Yang founded Visionly with Professor Zhao Mingwei, a leader in ophthalmology and optometry in China. Working with top academia partners such as Peking University and Wenzhou Medical University, Visionly further expanded its business while contributing to the ophthalmology industry’s cross-regional development. By combining Visionly’s knowledge and expertise with Humansa’s ecosystem in the Greater Bay Area, the partnership will bring high-quality eye care services to the region.

Ms Yang Lin, Co-founder & Chief Executive Officer of Visionly, said, “We have always believed in the market potential of the Greater Bay Area, and we are delighted to partner with Humansa. Supported by the resources of the New World Group ecosystem, our common goal is to build on each other’s strengths and capabilities, while expanding high-quality services and products in optometry. We believe that this collaboration will undoubtedly become an important driving force for our future development.”

為優質專業醫療護理服務奠定新基準

Humansa 之前宣布與卓正醫療和 SAINT BELLA 建立策略合作夥伴關係，作為其在大灣區擴展版圖的一部分。在與卓正醫療合作的基礎下，Humansa 於廣州天河區興建一間 4,000 平方米的小型醫院，計劃於 2022 年底投入服務。新的服務點將專注於為客戶提供專業醫療護理服務，如全身檢查、日間手術和其他門診服務。Humansa 與 SAINT BELLA 的戰略合作協議則旨在為初生嬰孩家長提供卓越的產後護理和諮詢。首個服務點已於 2022 年 1 月進駐香港 Victoria Dockside。

在新世界集團生態系統的支持下，Humansa 會繼續與秉承共同服務理念的合作夥伴攜手合作，並為顧客提供高質素醫健服務，透過更具協作性及個人化的服務模式提升顧客的醫健體驗。

新世界集團旗下醫療健康業務Humansa宣佈日前與貝康國際旗下的SAINT BELLA簽定戰略合作協議，銳意引領粵港澳大灣區母嬰護理產業發展，創新坐月護理服務理念。

關於 Humansa

Humansa （仁山優社）為新世界集團旗下的優質醫療健康業務，在大灣區打造一個突破性的醫健生態系統。為了進一步加強綜合醫健服務，Humansa 將與市場領導者繼續合作。通過國際公認的醫療專家及專業的顧問團隊，Humansa 致力於推動預防性健康管理。

Humansa 以人為本的使命為醫療健康行業帶來轉變。Humansa 以人性化的方式運作，並以最先進的科技為顧客帶來優質的服務。透過更具協作性及更個人化的服務模式，Humansa 旨在提升醫健體驗。

Humansa 在大灣區涵蓋廣泛的醫療健康服務，並分別與卓正醫療及 SAINT BELLA 建立戰略合作夥伴關係。Humansa 行政總裁蘇嘉威先生（右）到訪卓正醫療中心

關於諾亞醫療

Noah Healthcare is a well-known high-end doctor medical chain that focuses on the health of women and children. The Greater Bay Area accounts for over 80% of the company’s revenue, as it now has 15 high-end gynecological and pediatrics departments, which also offer obstetrics and dentistry services. In addition, auxiliary departments such as dermatology, nutrition, psychiatry, and others are gradually being added to Noah’s Healthcare’s scope. They are dedicated to creating a one-stop medical and health service center for women throughout their lives. Noah Medical works with over 300 well-known doctors, including directors and experts from leading hospitals. They also formed hospital alliances with the top six institutions and entered greenchannel referral collaboration agreements with a number of well-known top hospitals. They prioritize the health of their consumers and provide expert medical services for families seeking to improve their quality of life. Noah Healthcare Group has recently established itself as a wellknown medical service brand in China, with many well-known gynecologists and pediatric physicians. Noah’s Healthcare was named “Favorite Brand of Consumer Products” and “Top 100 Future Medical Services-Top 100 Medical Services in China” for four years in a row.

關於惟視眼科

After years of online and offline development, Visionly is one of the fastest growing optometry brands in Mainland China. It currently has New Vision Hospital and five optometry clinics, allowing it to completely fulfil all optometry and ophthalmology diagnosis and treatment needs. It includes the Youth Myopia Prevention and Control Center, Adult Refractive Surgery Center, High-end Cataract Surgery Center, Children’s Strabismus Amblyopia Correction Center, Specialist Clinic for High Myopia, and Complex Fundus Disease Diagnosis and Treatment Center, among other eye and optometry service centers. These clinics cater to middle- and upper-class clientele who require expert optometrist diagnosis and treatment throughout their lives. Ms Yang Lin, the company Chief Executive Officer, has extensive business development and managerial expertise with significant worldwide pharmaceutical experience, and a background in medicine. She founded Visionly in 2014 with Professor Zhao Mingwei, a leader in China in ophthalmology and optometry. She then expanded its online platform to offline, with the synthesized optometry service as a part of the medical platform. In addition, they collaborate with the leading ophthalmic schools, including Peking University and Wenzhou Medical University, to support the ophthalmology industry’s continued expansion and to actively deploy cross-regional development.